Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Linking Statistics With Testing Policy to Manage COVID-19 in the Community

Linking Statistics With Testing Policy to Manage COVID-19 in the Community

Authors: Hilborne LH, Wagner Z, Cabreros I, Brook RH

Citation: Am J Clin Pathol. 2020 Jun 10;aqaa099. doi: 10.1093/ajcp/aqaa099. Online ahead of print.

Specialties: COVID-19, Infectious disease

Download key summary

Related content

Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.